Eversept Partners, LP - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 136 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.65 and the average weighting 0.3%.

Quarter-by-quarter ownership
Eversept Partners, LP ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$17,552,049
+5.1%
2,479,103
+4.5%
1.48%
+6.4%
Q2 2023$16,699,676
-55.7%
2,372,113
-47.5%
1.40%
-46.9%
Q1 2023$37,702,838
+273.0%
4,520,724
+413.4%
2.63%
+197.1%
Q4 2022$10,107,991
+175.9%
880,487
+79.0%
0.88%
+105.8%
Q4 2020$3,664,297
-6.7%
491,852
-57.0%
0.43%
-50.7%
Q3 2020$3,926,930
-83.0%
1,143,211
-76.4%
0.87%
-72.4%
Q2 2020$23,099,729
+53.1%
4,847,792
-35.7%
3.17%
-15.5%
Q1 2020$15,084,744
-10.8%
7,542,372
+53.8%
3.75%
+25.5%
Q4 2019$16,920,387
+802.4%
4,904,460
+649.4%
2.99%
+413.4%
Q3 2019$1,875,028
+11.4%
654,460
+47.3%
0.58%
+23.6%
Q2 2019$1,683,745
-49.9%
444,260
+7.6%
0.47%
-51.9%
Q1 2019$3,360,811
+154.0%
412,876
+151.8%
0.98%
+36.9%
Q4 2018$1,323,149
+16.4%
163,959
+10.1%
0.72%
+43.5%
Q3 2018$1,136,557
+33.2%
148,9590.0%0.50%
+27.9%
Q2 2018$853,535
+20.1%
148,9590.0%0.39%
+18.2%
Q1 2018$710,534
-27.0%
148,959
-24.9%
0.33%
-41.1%
Q4 2017$973,746198,3190.56%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
VHCP Management, LLC 1,744,356$18,455,0009.59%
RA Capital Management 4,347,456$45,996,0003.30%
Cormorant Asset Management, LP 1,168,000$12,357,0002.84%
Baker Brothers Advisors 5,867,031$62,073,0000.79%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 907,920$9,606,0000.39%
QVT Financial LP 525,734$5,562,0000.32%
EAM Investors, LLC 114,548$1,212,0000.22%
FRANKLIN STREET ADVISORS INC /NC 93,000$984,0000.20%
THB ASSET MANAGEMENT 301,529$3,190,0000.19%
TPG Group Holdings (SBS) Advisors, Inc. 1,162,269$12,297,0000.13%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders